US Patent Issued to University of South Alabama Foundation for Research and Commercialization on Feb. 10 for "Enabling cholesterol catabolism in mammalian cells lacking same" (Alabama Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,918, issued on Feb. 10, was assigned to University of South Alabama Foundation for Research and Commercialization (Mobile, Ala.).

"Enabling cholesterol catabolism in mammalian cells lacking same" was invented by Richard Eric Honkanen (Mobile, Ala.), Brandon Marshall D'Arcy (Mobile, Ala.) and Mark Raymond Swingle (Mobile, Ala.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions, methods, and systems for modifying sterol metabolism in a subject is disclosed. In some embodiments, the subjects may be administered one or more mammalian cells modified to express at least one sterol degrading enzyme derived from a bacterium. In many embodiments, th...